PPARGC1A and Cognitive impairment: In a rat model of AD, direct intervention in the hippocampus with the 42 amino acid form of amyloid β (Aβ1–42) resulted in cognitive impairment by suppressing PGC1α/FNDC5/BDNF signaling [82].